Jiahui International Hospital Launches Cell Therapy Center for Global CAR-T Access
Jiahui International Hospital opened its International Cell Therapy Center on October 28, 2026, to expand access to CAR-T therapies for patients from China and abroad.
Reported by Jiahui International Hospital
Jiahui International Hospital launched the Jiahui International Cell Therapy Center on October 28, 2026, to expand access to CAR-T and cell therapies for international patients. The center builds on prior CAR-T cases, including treatment of patients from multiple countries.
According to the hospital, it treated China's first international patient with axicabtagene ciloleucel in 2023 and the first international patient with satri-cel, the world's first approved solid-tumor CAR-T, in 2026.
The launch responds to growing demand from overseas patients seeking advanced therapies in China. The hospital serves patients from 180 countries and regions annually.
Patients should confirm eligibility, availability, and costs directly with the hospital, as treatment options vary by individual case.
Source
Compiled from the hospital’s and media’s original reports and other public sources. Read the originals for full details.
prnewswire.comRead the original report